Half Yearly Results Webcast Presentation
24 January 2023
The Manager
ASX Market Announcements
Australian Securities Exchange
Exchange Centre
Level 4
20 Bridge Street
Sydney NSW 2000
Electronic Lodgement
Australian Foundation Investment Company Limited
Half Yearly Results Webcast Presentation
Please find attached the presentation to be given at the Shareholder Teleconference/
Webcast being held today, Tuesday 24 January 2023 at 3.30 p.m. (AEDT).
To join the webcast please use the below link (this will be made available on the
afi.com.au website).
Webcast Link: Please register for the results webcast here (This link will open directly
in your internet browser). Questions can be asked through the webcast link.
Conference Call
Alternatively to join via the teleconference, please register using the following link:
conference call registration link
Upon registering for the conference call you will have the option to dial in or to be
called directly. International dial in numbers are available through the registration
process.
You will be joined automatically to the conference. During the call you can indicate if
you would like to ask a question by pressing (*1) on your telephone keypad and wait
for your name to be announced.
The shareholder presentation material will be made available through our website.
ASX Release authorised by the Company Secretary, Matthew Rowe.
Half-Year Results
January 2023
Half-Year Results –January 2023
Australian Foundation Investment Company Limited and its subsidiary AICS (AFSL 303209), its
related entities and each of its respective directors, officers and agents (together the Disclosers)
have prepared the information contained in these materials in good faith. However, no warranty
(express or implied) is made as to the accuracy, completeness or reliability of any statements, estimates
or opinions or other information contained in these materials (any of which may change without notice)
and to the maximum extent permitted by law, the Disclosers disclaim all liability and responsibility
(including, without limitation, any liability arising from fault or negligence on the part of any or all of the
Disclosers) for any direct or indirect loss or damage which may be suffered by any recipient through
relying on anything contained in or omitted from these materials.
This information has been prepared and provided by AICS. To the extent that it includes any financial
product advice, the advice is of a general nature only and does not take into account any individual’s
objectives, financial situation or particular needs. Before making an investment decision an individual
should assess whether it meets their own needs and consult a financial advisor.
Disclaimer
2
Half-Year Results –January 2023
Overview and Investment ObjectivesMark Freeman
Financial ResultsAndrew Porter
Markets and the PortfolioDavid Grace
Recent Portfolio ActivityNga Lucas
OutlookDavid Grace
Agenda
2
33
Half-Year Results –January 2023
Overview and Investment Objectives
4
Half-Year Results –January 2023
Investment Objectives
The Company aims to provide
shareholders with attractive investment
returns through access to a growing
stream of fully franked dividends
and growth in capital invested.
The Company’s primary investment goals are:
• to pay dividends which, over time, grow
faster than the rate of inflation; and
• to provide attractive total returns over
the medium to long term.
5
Half-Year Results –January 2023
ESG Considerations are Integrated into Our Investment Framework
Approach to Environmental, Social and
Governance (ESG) Factors
•Long term sustainability of a company’s
business model is a key focus in our
assessment of quality.
•Assessment of ESG risk factors is an
important part of our investment process.
•We regularly review companies to ensure
ongoing alignment with our investment
framework.
Engagement with Companies
•We conduct our own evaluation of the merits
of any shareholder resolution and also take
input from proxy advisors.
•We vote on all company resolutions as part
of our regular engagement with companies.
•We actively engage with companies,
including when we have concerns those
resolutions are not aligned with shareholders’
interests.
6
Half-Year Results –January 2023
Financial Results
7
Half-Year Results –January 2023
* Assumes a shareholder can take full advantage of the franking credits.
Interim Result Summary – Six months to 31 December 2022
8
Half-Year Results –January 2023
Share Price Relative to NTA
9
Half-Year Results –January 2023
Markets and the Portfolio
10
Half-Year Results –January 2023
Valuation in a Long Term Context
Price to Sales – S&P/ASX 200 Index
Price to Book – S&P/ASX 200 Index
Average
1.9
Average
1.9
11
Half-Year Results –January 2023
Portfolio Set to Perform in Most Economic Settings
AFIC
Stalwarts
Growth Companies
IncomeCyclicals
17%
24%
26%
33%
12
Half-Year Results –January 2023
Portfolio* and Sector Performance to 31 December 2022
12 Month Sector Performance
* Assumes the full benefit of franking credits. Per annum returns other than for six months.
Past performance is not indicative of future performance.
Includes dividends but not franking.
13
Half-Year Results –January 2023
Reece: Long Term Investing
0
500
1,000
1,500
2,000
Reece Share Price vs S&P/ASX 200 Price Index
20 Year CAGR
Reece: 13.7%
S&P/ASX 200 Price Index: 4.5%
Reece Share PriceS&P/ASX 200 Price Index
14
Half-Year Results –January 2023
14.2%
14.1%
13.2%
10.7%
10.3%
9.7%
9.6%
7.2%
6.8%
6.6%
Quality Companies Find a Way to Grow
Sales Growth Per Annum Since Our First Purchase
Holding
since
2015
Holding
since
2014
Holding
since
2010
Holding
since
2013
Holding
since
2013
Holding
since
2018
Holding
since
2016
Holding
since
2013
Holding
since
2016
Holding
since
1999
Sales from FY02
3.2%
S&P/ASX 200
10 Year Sales CAGR
15
Half-Year Results –January 2023
Recent Portfolio Activity
16
Half-Year Results –January 2023
Active Portfolio Management – Recent Transactions
New PurchasesSalesAdditions to Existing Holdings
Complete Disposals
17
Half-Year Results –January 2023
Wesfarmers
Wesfarmers is a conglomerate that operates a number of large, well
known retail brands including Bunnings, Officeworks, Kmart and Target.
Bunnings is one of the best retailers in the world generating very
attractive shareholder returns.
Bunnings is a key driver of earnings growth at >60% of group
earnings, with a long growth runway.
Wesfarmers’ strategy is to continually establish new businesses
and invest in existing businesses to provide a ‘satisfactory’ return
to shareholders in the long term.
18
Half-Year Results –January 2023
Auckland Airport
Auckland Airport owns a highly unique and strategic
infrastructure asset.
Freehold nature and large undeveloped landbank offers opportunity
for long term growth.
Expect post COVID international passenger recovery to drive
earnings growth, currently at over 70% vs 2019.
Strong balance sheet and experienced management team.
19
Half-Year Results –January 2023
PEXA
A pioneer and leader in digital property settlements
in Australia.
Handles >80%ofproperty transfer transactionsand>90%
of refinancingtransactionsin Australia.
Has developeda deepnetworkofpractitionerfirms, financial
institutions, the RBA,landtitles offices and state revenueoffices.
PEXA is uniquely positioned to take its know-howto larger offshore
markets, starting in the United Kingdom.
20
Half-Year Results –January 2023
Outlook
21
Half-Year Results –January 2023
Outlook
The effects of inflation and high living costs are placing pressure on parts of the economy.
Market valuations are slightly above long term averages with some downside risk.
We remain focused on companies well positioned to create long term shareholder value.
The portfolio is invested in well managed companies with proven track records of financial
discipline capturing value-accretive opportunities as they arise.
22
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: 221124 Interim results FY23H1 App 2 amended2022-11-23
“Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 6 months to September 30 2022 Previous Reporting Period 6 months to September 30 2021 Currency NZ$ Amount (000s) Percentage change Revenue from continuing operations $65,750 Up 18%…”